Cetera Advisor Networks’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-7,106
| Closed | -$245K | – | 2127 |
|
2022
Q1 | $245K | Sell |
7,106
-2,027
| -22% | -$69.9K | ﹤0.01% | 1765 |
|
2021
Q4 | $400K | Sell |
9,133
-703
| -7% | -$30.8K | ﹤0.01% | 1422 |
|
2021
Q3 | $499K | Buy |
9,836
+6
| +0.1% | +$304 | 0.01% | 1229 |
|
2021
Q2 | $511K | Buy |
9,830
+122
| +1% | +$6.34K | 0.01% | 1168 |
|
2021
Q1 | $444K | Buy |
+9,708
| New | +$444K | 0.01% | 940 |
|